Cosmo Pharmaceuticals logo

Cosmo Pharmaceuticals

We develop innovative treatments that address significant unmet clinical needs

202 employees · est. 1997 · Dublin, Ireland

VS
Shorla Oncology logo

Shorla Oncology

At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers.

38 employees · est. 2018 · Ireland

Cosmo Pharmaceuticals is the older company (1997 vs 2018); Cosmo Pharmaceuticals is the larger of the two.

Side-by-Side Comparison

Cosmo Pharmaceuticals Shorla Oncology
Founded
1997 older 2018
Headquarters
Dublin, Ireland Ireland
Employees
202 larger 38
Industry
Biotechnology, Health Care, Manufacturing Health Care, Manufacturing, Pharmaceutical
Funding Stage
Post Ipo Debt Series B
Total Funding
$25.00M $43.30M
Funding Rounds
1 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Pharmaceuticals, Specialty Drugs, Gastroenterology, Endoscopy, Clinical Development, Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn's Disease, Colon Infections, Drug Manufacturing, Colonoscopy, Clinical Trials, Nutraceuticals, Medical Research, Innovative Treatments Oncology Drugs, Cancer Treatments, Women's Health, Pediatric Oncology, Drug Development, Commercialization, Unmet Medical Needs, Clinical Impact, Innovation, Life-saving Treatments
Website
cosmopharma.com shorlaoncology.com
Cosmo Pharmaceuticals logo

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals Analysis: Cosmo Pharmaceuticals is a biotechnology and pharmaceutical company based in Ireland, founded in 1996. The company's slogan "We develop innovative treatments that address significant unmet clinical needs" underscores its commitment to pioneering medical solutions. Cos...

Shorla Oncology logo

About Shorla Oncology

Shorla Oncology is an Irish healthcare startup that focuses on the development and commercialization of innovative oncology drugs, particularly targeting women's and pediatric cancers. Founded in 2018, the company's mission is to address the gaps in existing cancer treatments by providing accessible...

We will tell you when either one moves

BounceWatch watches Cosmo Pharmaceuticals and Shorla Oncology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cosmo Pharmaceuticals and Shorla Oncology — by email.

Frequently Asked Questions

Cosmo Pharmaceuticals — We develop innovative treatments that address significant unmet clinical needs. Shorla Oncology — At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cosmo Pharmaceuticals has raised $25.00M while Shorla Oncology has raised $43.30M.
Cosmo Pharmaceuticals and Shorla Oncology operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cosmo Pharmaceuticals with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Cosmo Pharmaceuticals on 12 Sep 2024, and Shorla Oncology on 25 Feb 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy